US Patent Issued to Regents of the University of Minnesota on July 29 for "Activation of resident memory T cells for the treatment of cancer" (Minnesota Inventors)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,370,256, issued on July 29, was assigned to Regents of the University of Minnesota (Minneapolis).

"Activation of resident memory T cells for the treatment of cancer" was invented by David B. Masopust Jr. (Minneapolis) and Vaiva D. Vezys (Minneapolis).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are improved methods of treating cancer in humans by activating resident memory T cells in tumors using one or more antigenic peptides."

The patent was filed on Aug. 3, 2018, under Application No. 16/635,205.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=H...